Munafa Stock Market Course + Intraday & FNO calls 
Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Autolus Therapeutics (AUTL)
Technical Analysis Report for NASDAQ stock AUTL Autolus Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUTL Autolus Therapeutics then click here. or read Experts views on Autolus Therapeutics or Forecast & share price targets of Autolus Therapeutics
Autolus Therapeutics Opened at 1.34 and Closed at: 1.42, which is 7.04% of previous session's close. It moved within a range of 1.33 and 1.43
The session was a Bullish session with an average volume of 1176600, which is -72.59% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 1.38 and resistance for tomorrow is 1.48
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.36, 1.29 resistance for tomorrow's hourly charts is 1.46, 1.49
10 Day SMA for Autolus Therapeutics (AUTL) is 1.4 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Autolus Therapeutics (AUTL) is 1.44 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Autolus Therapeutics (AUTL) is 1.56 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.53 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Autolus Therapeutics is 1.71 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Autolus Therapeutics is at 1.44 and 200 DMA is at 1.71, while 50 DMA and 100 DMA are at 1.56 and 1.53 respectively
Autolus Therapeutics (AUTL) moving average of 20 SMA is at 1.44 and 20 EMA is at 1.46
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 1.42 | 1.44 | 1.46 |
| 05 Thu Feb | 1.32 | 1.46 | 1.46 |
| 04 Wed Feb | 1.38 | 1.49 | 1.48 |
| 03 Tue Feb | 1.39 | 1.52 | 1.49 |
| 02 Mon Feb | 1.39 | 1.55 | 1.5 |
| 30 Fri Jan | 1.37 | 1.57 | 1.51 |
Autolus Therapeutics (AUTL) moving average of 50 SMA is at 1.56 and 50 EMA is at 1.5
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 1.42 | 1.56 | 1.5 |
| 05 Thu Feb | 1.32 | 1.56 | 1.5 |
| 04 Wed Feb | 1.38 | 1.56 | 1.51 |
| 03 Tue Feb | 1.39 | 1.56 | 1.52 |
| 02 Mon Feb | 1.39 | 1.55 | 1.53 |
| 30 Fri Jan | 1.37 | 1.55 | 1.54 |
Autolus Therapeutics (AUTL) moving average of 100 SMA is at 1.53 and 100 EMA is at 1.62
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 1.42 | 1.53 | 1.62 |
| 05 Thu Feb | 1.32 | 1.52 | 1.62 |
| 04 Wed Feb | 1.38 | 1.53 | 1.63 |
| 03 Tue Feb | 1.39 | 1.53 | 1.63 |
| 02 Mon Feb | 1.39 | 1.53 | 1.63 |
| 30 Fri Jan | 1.37 | 1.53 | 1.63 |
Autolus Therapeutics (AUTL) moving average of 200 SMA is at 1.71 and 200 EMA is at 1.86
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 1.42 | 1.71 | 1.86 |
| 05 Thu Feb | 1.32 | 1.71 | 1.86 |
| 04 Wed Feb | 1.38 | 1.71 | 1.87 |
| 03 Tue Feb | 1.39 | 1.71 | 1.87 |
| 02 Mon Feb | 1.39 | 1.71 | 1.87 |
| 30 Fri Jan | 1.37 | 1.71 | 1.87 |
Dentsply Sirona has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 29.13% more returns!
Twist Bioscience has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 60.96% more returns!
Repros Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Repros Therapeutics, about 32.7% more returns!
Puma Biotechnology has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Puma Biotechnology, about 35.3% more returns!
Autolus Therapeutics has performed better than Myriad Genetics in short term. Holding Autolus Therapeutics could be a better choice for now!
Moderna Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 41.15% more returns!
Madrigal Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Madrigal Pharmaceuticals, about 14.46% more returns!
Autolus Therapeutics has performed better than Lifevantage Corporation in short term. Holding Autolus Therapeutics could be a better choice for now!
Arbutus Biopharma has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 4.88% more returns!
Aldeyra Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 56.1% more returns!
Catalyst Biosciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 9.69% more returns!
Cerus Corporation has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Cerus Corporation, about 28.87% more returns!
Cellectar Biosciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 20.25% more returns!
Corvus Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 223.32% more returns!
Champions Oncology has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 18.02% more returns!
Dare Bioscience has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 6.05% more returns!
Enanta Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 24.6% more returns!
Gilead Sciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 47.48% more returns!
Autolus Therapeutics Technical analysis of indicators
Price action analysis of Autolus Therapeutics (AUTL) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Autolus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Autolus Therapeutics in short term and the sell signal is strong.
Autolus Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Autolus Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Autolus Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.39 and Autolus Therapeutics AUTL stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Autolus Therapeutics AUTL stock. Volume based technical analysis of Autolus Therapeutics AUTL stock is negative.
Autolus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock AUTL Autolus Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUTL Experts View which covers a lot of information including buying and selling signals
AUTL future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Autolus Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
